We are pleased to announce the results of the 2021 Board elections. Congratulations to the following members who will be elected to the Board of Directors later this year.
2021 Board of Directors
VICE President (2021-2022)
Nicholas J. Shaheen
I am a gastroenterologist and professor of medicine at the University of North Carolina School of Medicine, and Chief of the Division of Gastroenterology and Hepatology at UNC. I specialize in endoscopic treatment of precancerous and cancerous conditions of the esophagus, and am an active clinical researcher in these areas. I am a longstanding member of the ISDE and support its mission. The unique multidisciplinary and international nature of the group provides a perspective not found elsewhere, and leads to enriched and stimulating academic interaction. I have enjoyed serving as a co-chair of the planning committee for our upcoming virtual Congress, and addressing the challenges presented by mounting a meeting in the time of a pandemic.
I have extensive administrative experience, both at my institution and in professional organizations, which make me well-suited for this position. In addition to managing our GI division and the clinical research center here at UNC, I have served as the Director of the American College of Gastroenterology Institute, the research and education arm of the ACG. I have also been a trustee of that organization for the past decade. I also served the American Gastroenterological Association as head of the Clinical Practice section, and a member of AGA Council. I am highly collaborative and believe that the best ideas to engage a professional society usually originate from the membership up, not the leadership down. I am honored to be considered for this position, and if selected, will work hard to promote the ISDE in national and international venues.
csde dIRECTOR (2021-2023)
First of all, it is a great honor for me to be nominated for the period of 2021-2022 as Director of the ISDE Board.
Being an active member of ISDE since 1994, I attended most of the ISDE conferences since 1998. It was a significant experience for me to witness the growing and strengthening of ISDE, now to be the most representative and impacted societies in the world. As for China, I founded Chinese Society for Diseases of the Esophagus (CSDE) in 2015 in order to improve the current unsatisfactory quality of medical care. The Society is focused on improving the medical service quality by enhancing medical education and training, bridging international collaboration and coordinate clinical studies.
As one of the 2 affiliated societies to ISDE, CSDE represents a combined initiative amongst Chinese surgeons, physicians, pathologists and scientists to study esophageal diseases. Later on, we promoted over 120 abstracts submission and 90 attendees to ISDE 2016 in Singapore. It would be the similar expectation for ISDE 2018 in Vienna. What’s more, the “CSDE Annual Working Conference 2020 ” was successfully held in Shenzhen, China. It brought together multiple specialties focused on the clinical management and research of patients with esophageal diseases. Since its inception, CSDE has been playing as an excellent platform for the academic exchange of clinical and scientific knowledge on the latest developments.
I am willing to initiate or chair some task forces assigned by ISDE, already with experience with being enrolled in the WECC task force to define the 7th and 8th edition of TNM staging for esophageal cancer. I am keeping communication and also serving in other local relevant societies in China like Esophageal Cancer Committee, Chinese Anti-Cancer Association (CACA), and Esophageal Expertise Committee, Chinese Association for Thoracic Surgeons (CATS).
ESDE Director (2021-2023)
I am professor of surgery and head of the Division of Surgery at the Department of Clinical Science, Intervention and Technology at Karolinska Institutet in Stockholm, Sweden.
My clinical work is mainly dedicated to esophageal and gastric cancer surgery, but I also do quite a bit of benign esophageal work, including hiatal hernia repair and management of esophageal perforations and airway fistulas. My main scientific interests are oriented towards optimizing management of esophageal cancer patients, with a particular interest in neoadjuvant therapies and tailoring of lymphadenectomy and minimally invasive surgical techniques.
I am the past President of the European Society for Diseases of the Esophagus, the Swedish Society of Upper Abdominal Surgery and currently the Chairman of the Swedish National Registry for Gastric and Esophageal Cancer. I have a particular interest in multidisciplinary collaboration, and I am much involved in several oncological associations, for example as a faculty member of the upper gastrointestinal group of the European Society for Medical Oncology (ESMO) and a member of the European Organization for Research and Treatment of Cancer (EORTC) gastrointestinal group. As a result of many years of multidisciplinary collaboration I have led and currently lead some international randomized multicenter trials in the crossroads of surgery and oncology, such as the completed NeoRes I and II trials and the currently ongoing NEEDS trial.
I am also an associate editor of Diseases of the Esophagus since 2015 and the work with our great journal is something that I consider extremely important and always try to prioritize. I would be very happy and honored if I would be given the chance to serve as a director in the ISDE board and I would then take the opportunity to work hard to further develop multidisciplinary and international collaboration in the interests of the ISDE.
After graduation from Chulalongkorn University Dr. Mahachai undertook post graduate training in internal medicine and gastroenterology at the University of Alberta, Canada and Postdoctoral Fellowship in clinical pharmacology at the University of California, San Francisco.
She served as a faculty member in the Division of Gastroenterology, University of Alberta from 1985 to 1990.In 1990 she joined Chulalongkorn University where she has been actively involved in teaching, research and patient care. She served as a Chief of the Division of Gastroenterology for two consecutive terms (2004 – 2008). Dr.Varocha Mahachai is a Past-President of the Gastroenterological Association of Thailand. Currently, she is an advisor to Bangkok GI and Liver Center and a GI Director at Sukhumvit Hospital in Bangkok and an academic advisor to the Dean of CICM, Thammasat University. She now serves as committee members in various International Societies: Council member (Co-opt), Chairman Award Committee, Asian-Pacific Gastroenterological Association (APAGE).She is a member of Publication Committee of World Gastroenterology Organization (WGO).Dr. Mahachai serves on the editorial board of Helicobacter and JNM. In addition, she is a corresponding fellow in Asia for the European Helicobacter Study Group and a member of a Healthy Stomach Initiative group. Dr. Mahachai also serves as member for Scientific Committee of WGO and APDW.
She is also a Director of National Gastric Cancer and Helicobacter Pylori Research Center in Thailand. Her major interests include all areas of digestive systems in GI, Hepatology, Endoscopy with special interests in Helicobacter pylori, Hepatitis B&C,HCC,GERD,Esophageal cancer, Colon cancer, IBD and microbiota research. She recently participated in the ESCC Screening WEO consensus.
First of all, I am honored to be nominated for membership of the Board of the ISDE.
I am Professor of Division of Gastroenterology and Hepatology, Department of Medicine at Nihon University School of Medicine. I am also serving as the Dean of Nihon University School of Medicine from November 2020.
I, Takuji Gotoda, MD, Ph.D. FASGE, FACG, FRCP, am graduated from Tokyo Medical University in 1992. After the internship, I started residency for Gastrointestinal Oncology from 1995 and was appointed the Chief of the Endoscopy Division at National Cancer Center Hospital from 2006. I have received ASGE Audiovisual Award in 2005 and 2010. I have served in the board member of Digestion, Gastric Cancer, Digestive Endoscopy and Gastrointestinal Endoscopy, and the council of the Japanese Gastric Cancer Association, Japanese Society of Gastroenterology, Japanese Gastroenterological Endoscopy Society, and Japanese Society of Gastroenterology. I have also been honored as a Fellow of ASGE from 2012, ACG from 2015, and RCP from 2015.
My clinical research is focused on gastric cancer because the incidence is much higher than others. Especially, I am honored to develop endoscopic submucosal dissection (ESD) as a new endoscopic technique. Furthermore, my efforts were involved in standardizing ESD and making treatment indication. My recent research interest is in following areas; diagnosis of Barrett’s esophagus, etiology of Barrett’s esophagus, early detection of Barrett’s esophageal adenocarcinoma, endoscopic treatment of Barrett’s adenocarcinoma and so on.
I have 280 publications in peer-review journals with more than 22,700 citations and a current H-index of 72.
It would be an honor to continue to represent our interests and keep working on improving the society.
ISDE News Corner